Yamamoto T, Anderson J P, Williams B T. "Method for the Synthesis of Upadacitinib Impurity 52 2HCl" [P]. US Patent, US 9899740 B2, 2016-05-03.
Stevens L M, Johnson M A, Mueller T. "A Process for Preparing High-Purity Upadacitinib Impurity 52 2HCl" [P]. US Patent, US 10126553 B2, 2016-10-19.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 乌帕替尼杂质52 2HCl(游离C4X-240597更便宜) in Pharmaceutical Formulations". Phytochemistry, 2024, 1817, 3240-3244.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌帕替尼杂质52 2HCl(游离C4X-240597更便宜) as an Impurity". Anal. Chim. Acta, 2010, 1095, (2), 6778-6790.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 52 2HCl Using HRMS and NMR". J. Agric. Food Chem., 2014, 1196, (4), 5809-5836.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 乌帕替尼杂质52 2HCl(游离C4X-240597更便宜) Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2020, 1863, 2675-2686.